Clustering-based time series analysis on insulin response in the blood-brain barrier
Krishna R. KalariiD, Zengtao WangiD, Xiaojia TangiD, Suresh Kumar Swaminathan, Karunya K. KandimallaiD
Abstract
BackgroundCritical functions of the blood-brain barrier (BBB), including cerebral blood flow and vascular response, are regulated by insulin signaling pathways. Therefore, endothelial insulin resistance could lead to vascular dysfunction, which is associated with neurodegenerative diseases such as Alzheimers disease (AD). ObjectiveThe objective of the current study is to map the dynamics of insulin-responsive pathways in polarized human cerebral microvascular endothelial cells (hCMEC/D3) cell monolayers, a widely used BBB cell culture model, to identify molecular mechanisms underlying BBB dysfunction in AD. MethodsRNA-Sequencing (RNA-Seq) was performed on hCMEC/D3 cell monolayers with and without insulin treatment at various time points. The Short Time-series Expression Miner (STEM) method was used to identify clusters of genes with distinct and representative patterns. Functional annotation and pathway analysis of the genes from top clusters were conducted using the Webgestalt and Ingenuity Pathway Analysis (IPA) software, respectively. ResultsQuantitative expression differences of 19,971 genes between the insulin-treated and control monolayers at five-time points were determined. STEM software identified 11 clusters with 3061 genes across that displayed various temporal patterns. Gene ontology enrichment analysis performed using the top 5 clusters demonstrated that these genes were enriched in various biological processes associated with AD pathophysiology. The IPA analyses revealed that signaling pathways exacerbating AD pathology such as inflammation were downregulated after insulin treatment (clusters 1 to 3). In contrast, pathways attenuating AD pathology were upregulated, including synaptogenesis and BBB repairment (clusters 4 and 5). ConclusionsThese findings unravel the dynamics of insulin action on the BBB endothelium and inform about downstream signaling cascades that potentially regulate neurovascular unit (NVU) functions that are disrupted in AD.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- ACUTE AMYLOID-B 40 EXPOSURE DISRUPTS METABOLIC INSULIN SIGNALING IN BLOOD-BRAIN BARRIER ENDOTHELIAL CELLS
Douglas B. Nelson, Krishna R. Kalari, Karunya K. Kandimalla·bioRxiv·Nov 21, 2025
- Cerebrovascular insulin receptors are defective in Alzheimer's disease
M. Leclerc, Philippe Bourassa, … Frédéric Calon·bioRxiv·Dec 1, 2021
- Endothelial-pericyte interactions activate insulin signaling and its implications for blood-brain barrier dysfunction in Alzheimers disease
Zengtao Wang, Vaishnavi Veerareddy, … Karunya K. Kandimalla·bioRxiv·Nov 24, 2025
- Amyloid Beta Peptides Inhibit Glucose Transport at the Blood-brain Barrier by Disrupting Insulin-Akt Pathway in Alzheimer's Disease
L. Wang, G. L. Curran, … K. K. Kandimalla·bioRxiv·Nov 21, 2022
- Inflammatory reprogramming of human brain endothelial cells compromises blood-brain barrier integrity in Alzheimer's disease
Rebecca L. Pinals, Rezaul Islam, … Li‐Huei Tsai·bioRxiv·Sep 26, 2025
- Inhibition of β-catenin signaling by Amyloid-β in endothelial cells impairs vascular barrier integrity
Joseph W. Leasure, Thi Mai, … Jalees Rehman·bioRxiv·Nov 5, 2024